Literature DB >> 12107151

The mexR repressor of the mexAB-oprM multidrug efflux operon in Pseudomonas aeruginosa: characterization of mutations compromising activity.

Lateef Adewoye1, Ainsley Sutherland, Ramakrishnan Srikumar, Keith Poole.   

Abstract

Mutations in mexR yield a multidrug resistance phenotype in nalB mutants of Pseudomonas aeruginosa as a result of derepression of the mexAB-oprM multidrug efflux operon. MexR produced by several nalB strains carried single amino acid changes that compromised MexR stability or its ability to dimerize. Changes at residues L95 and R21, however, produced a stable MexR protein capable of dimerization and, thus, likely compromised DNA binding.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12107151      PMCID: PMC135222          DOI: 10.1128/JB.184.15.4308-4312.2002

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  25 in total

Review 1.  The mar regulon: multiple resistance to antibiotics and other toxic chemicals.

Authors:  M N Alekshun; S B Levy
Journal:  Trends Microbiol       Date:  1999-10       Impact factor: 17.079

2.  Influence of mutations in the mexR repressor gene on expression of the MexA-MexB-oprM multidrug efflux system of Pseudomonas aeruginosa.

Authors:  R Srikumar; C J Paul; K Poole
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

3.  Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa.

Authors:  S Jalal; B Wretlind
Journal:  Microb Drug Resist       Date:  1998       Impact factor: 3.431

4.  A new LexA-based genetic system for monitoring and analyzing protein heterodimerization in Escherichia coli.

Authors:  M Dmitrova; G Younès-Cauet; P Oertel-Buchheit; D Porte; M Schnarr; M Granger-Schnarr
Journal:  Mol Gen Genet       Date:  1998-01

5.  Influence of the TonB energy-coupling protein on efflux-mediated multidrug resistance in Pseudomonas aeruginosa.

Authors:  Q Zhao; X Z Li; A Mistry; R Srikumar; L Zhang; O Lomovskaya; K Poole
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

6.  Rapid identification of mutations in a multidrug efflux pump in Pseudomonas aeruginosa.

Authors:  S Jalal; G Wretlind; N Gotoh; B Wretlind
Journal:  APMIS       Date:  1999-12       Impact factor: 3.205

7.  Inner membrane efflux components are responsible for beta-lactam specificity of multidrug efflux pumps in Pseudomonas aeruginosa.

Authors:  R Srikumar; X Z Li; K Poole
Journal:  J Bacteriol       Date:  1997-12       Impact factor: 3.490

8.  Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain.

Authors:  R Srikumar; T Kon; N Gotoh; K Poole
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

9.  nalB-type mutations causing the overexpression of the MexAB-OprM efflux pump are located in the mexR gene of the Pseudomonas aeruginosa chromosome.

Authors:  K Saito; H Yoneyama; T Nakae
Journal:  FEMS Microbiol Lett       Date:  1999-10-01       Impact factor: 2.742

10.  In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM.

Authors:  I Ziha-Zarifi; C Llanes; T Köhler; J C Pechere; P Plesiat
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

View more
  24 in total

1.  In vivo and in vitro evidence that TtgV is the specific regulator of the TtgGHI multidrug and solvent efflux pump of Pseudomonas putida.

Authors:  Antonia Rojas; Ana Segura; María Eugenia Guazzaroni; Wilson Terán; Ana Hurtado; María Trinidad Gallegos; Juan L Ramos
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

2.  MarR-like transcriptional regulator involved in detoxification of aromatic compounds in Sulfolobus solfataricus.

Authors:  Gabriella Fiorentino; Raffaele Ronca; Raffaele Cannio; Mosè Rossi; Simonetta Bartolucci
Journal:  J Bacteriol       Date:  2007-08-03       Impact factor: 3.490

3.  Protein modulator of multidrug efflux gene expression in Pseudomonas aeruginosa.

Authors:  Denis M Daigle; Lily Cao; Sebastien Fraud; Mark S Wilke; Angela Pacey; Rachael Klinoski; Natalie C Strynadka; Charles R Dean; Keith Poole
Journal:  J Bacteriol       Date:  2007-06-01       Impact factor: 3.490

4.  Critical biophysical properties in the Pseudomonas aeruginosa efflux gene regulator MexR are targeted by mutations conferring multidrug resistance.

Authors:  Cecilia Andrésen; Shah Jalal; Daniel Aili; Yi Wang; Sohidul Islam; Anngelica Jarl; Bo Liedberg; Bengt Wretlind; Lars-Göran Mårtensson; Maria Sunnerhagen
Journal:  Protein Sci       Date:  2010-04       Impact factor: 6.725

Review 5.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

6.  Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates.

Authors:  John Quale; Simona Bratu; Jyoti Gupta; David Landman
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

Review 7.  MarR family proteins are important regulators of clinically relevant antibiotic resistance.

Authors:  Grace A Beggs; Richard G Brennan; Mehreen Arshad
Journal:  Protein Sci       Date:  2019-11-14       Impact factor: 6.725

Review 8.  Regulation of bacterial drug export systems.

Authors:  Steve Grkovic; Melissa H Brown; Ronald A Skurray
Journal:  Microbiol Mol Biol Rev       Date:  2002-12       Impact factor: 11.056

Review 9.  Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Authors:  Philip D Lister; Daniel J Wolter; Nancy D Hanson
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

Review 10.  Efflux-mediated drug resistance in bacteria.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.